Entest Biomedical, Inc. Declares Dividend of Preferred Stock

SAN DIEGO--(BUSINESS WIRE)--Entest BioMedical Inc. (OTCQB: ENTB), a veterinary biotechnology company and operator of veterinary hospitals, today announced the declaration of a dividend of one share of the Company’s Series B Preferred Stock for every eight shares of Entest BioMedical, Inc. Common Stock owned as of the Record Date. The Record date is February 21, 2012 and the dividend is set to be paid on or about February 28, 2012.